What does Crescent Capital BDC do?
Crescent Capital BDC, Inc. is a Nasdaq-listed business development company, or BDC, that lends primarily to private U.S. middle-market businesses. Rather than operating factories, stores, or software platforms, CCAP owns a portfolio of loans and selected equity interests. Its economic purpose is to convert underwriting expertise, sponsor relationships, and balance-sheet leverage into recurring investment income while preserving net asset value. The company describes its objective as generating current income and capital appreciation through debt investments in privately held companies, a model summarized on its official investor-relations site.
A listed lender rather than an operating company
The portfolio spans 18 industries and is built mostly from senior secured loans to sponsor-backed borrowers. Crescent’s adviser sources transactions, conducts credit analysis, negotiates terms, monitors borrowers, and manages restructurings. Shareholders therefore own a publicly traded claim on a diversified private-credit book, not direct ownership of the adviser’s broader asset-management platform.
Why the BDC and RIC structure matters
CCAP has elected regulation under the Investment Company Act of 1940 and intends to maintain regulated investment company tax treatment. Those choices shape the model: qualifying assets must dominate the portfolio, leverage is constrained by asset-coverage rules, and at least 90% of taxable income generally must be distributed to preserve pass-through tax treatment. The structure supports a high-payout profile, but it also limits retained earnings and makes access to debt and equity capital important. The company’s SEC registration statement explains these operating constraints.
How does CCAP make money?
The core revenue source is interest collected on debt investments. Borrowers typically pay a floating benchmark rate plus a negotiated credit spread, and some loans also produce upfront fees, amendment fees, prepayment income, or payment-in-kind interest. Dividend income from equity positions and investment vehicles provides a smaller, less predictable contribution. CCAP then subtracts borrowing costs, management and incentive fees, administrative expenses, and credit losses to arrive at net investment income and the change in net assets from operations.
Where investment income comes from
| Revenue stream | Economic driver | Research implication |
|---|---|---|
| Cash interest | Portfolio size, base rates, contractual spreads, and non-accrual levels | Usually the largest and most recurring income source |
| PIK interest | Accrued rather than immediately paid cash interest | Supports accounting income but deserves scrutiny for cash conversion |
| Fees and prepayments | Origination, amendment, exit, and early-repayment activity | Can make quarterly income uneven |
| Dividends and equity gains | Performance of equity co-investments and controlled vehicles | Offers upside but is less dependable than contractual loan income |
How leverage and fee economics convert yield into NII
A BDC earns a spread between portfolio yield and the combined cost of debt, operating expenses, and adviser compensation. In Q1 2026, CCAP’s weighted-average yield on income-producing securities was 9.8%, while its weighted-average cost of debt was 6.09%. That spread is not the same as shareholder return because some assets are equity-funded and because management fees, incentive fees, defaults, and fair-value changes sit between gross yield and net income.
First-Lien Concentration and Floating-Rate Exposure Define the Portfolio
CCAP’s portfolio is intentionally concentrated in senior positions. At March 31, 2026, senior secured first-lien loans, unitranche first-lien loans, and unitranche last-out loans represented 92.1% of fair value. This positioning does not eliminate losses, but it generally places the lender ahead of junior capital in a restructuring and gives it stronger collateral and covenant rights than unsecured creditors.
Which credit instruments dominate?
| Asset category | Fair value | Portfolio share | Interpretation |
|---|---|---|---|
| Unitranche first lien | $1,044.0M | 66.7% | The main earnings engine and largest credit concentration |
| Traditional first lien | $377.0M | 24.2% | Adds seniority and collateral protection |
| Equity and other | $69.6M | 4.5% | Potential appreciation with less contractual downside protection |
| LLC and LP interests | $31.3M | 2.0% | Includes investment-vehicle exposure with different cash-flow timing |
Where is concentration located?
Industry exposure is led by healthcare equipment and services at 26%, software and services at 20%, and commercial and professional services at 17%. Consumer services contributes 9% and insurance 6%; the remaining industries and the Logan joint venture provide the balance. The book is geographically concentrated in the United States, while obligor concentration is comparatively modest: the top ten positions represent 17% of the portfolio and the average position is about $8 million.
What does CCAP’s latest quarter show?
The quarter ended March 31, 2026 showed stable distributable earnings but a meaningful decline in net asset value. In its Q1 2026 earnings release, CCAP reported net investment income of $0.42 per share, exactly matching the prior regular quarterly dividend. However, realized and unrealized losses reduced net income to a loss of $0.42 per share and pushed NAV down to $18.27 per share.
Income held up, but credit marks weakened NAV
| Metric | Q1 2026 | Q4 2025 | What changed |
|---|---|---|---|
| Investment income | $37.9M | $40.8M | Lower benchmark rates and restructurings reduced interest income |
| Net investment income | $15.5M | $16.5M | Earnings remained positive but softened sequentially |
| NAV per share | $18.27 | $19.10 | A 4.3% quarterly decline, driven by realized and unrealized losses |
| Portfolio fair value | $1,562.5M | $1,569.4M | Net funding was offset by valuation changes and repayments |
| Weighted-average portfolio yield | 9.8% | 10.0% | Falling base rates compressed asset yield |
Why the fee reduction changes forward economics
Effective April 1, 2026, the adviser permanently reduced the base management fee from 1.25% to 1.00% and the income incentive fee from 17.5% to 15.0%, while keeping the 7.0% hurdle rate. This does not repair credit marks, but it lowers the recurring expense drag and improves alignment. The company declared a Q2 2026 regular dividend of $0.34 per share plus three special dividends totaling $0.09 per share, signaling a reset toward a more sustainable base payout with supplemental distributions when earnings allow. The related filing is available through the Q1 2026 SEC earnings exhibit.
How did Crescent BDC reach its current scale?
CCAP’s current portfolio and governance structure are the result of adviser development, two major BDC combinations, and a shift toward permanent public capital. The history matters because acquisitions expanded assets and diversification, while external management ties the company’s underwriting capability to Crescent Capital Group’s broader private-credit platform.
Six turning points that still matter
-
1991Crescent Capital’s predecessor was founded around below-investment-grade credit. That long credit-cycle experience underpins today’s adviser proposition.
-
2015CCAP was formed and began investment operations, creating the vehicle through which public shareholders would access the strategy.
-
2020The acquisition of Alcentra Capital closed and CCAP began trading on Nasdaq. The transaction broadened the portfolio and established public-market liquidity.
-
2021Sun Life completed its majority investment in the adviser, adding institutional distribution and balance-sheet support while Crescent retained its specialist credit identity.
-
2023The First Eagle Alternative Capital BDC merger created a pro forma company with more than $1.6 billion of assets and increased borrower diversification.
-
2026Permanent fee reductions and a lower regular dividend reset the expense and payout framework after falling rates and credit marks pressured earnings and NAV.
The adviser’s institutional roots are described in Crescent Capital’s Sun Life transaction announcement. CCAP’s own scale changed more directly through the Alcentra acquisition and the later First Eagle BDC merger. For researchers, the key point is that portfolio growth came partly from corporate combinations, not solely from organic originations.
Scale, Sponsorship, and Underwriting Form the Competitive Position
CCAP competes in a crowded direct-lending market against large public BDCs, private credit funds, banks, insurance capital, and specialty finance firms. Relevant public comparison companies include Ares Capital, Blue Owl Capital Corporation, Golub Capital BDC, Blackstone Secured Lending Fund, and Oaktree Specialty Lending. These rivals often have larger balance sheets or broader origination channels, so CCAP’s case rests less on absolute size and more on sourcing quality, underwriting selectivity, portfolio construction, and adviser resources.
What is genuinely differentiated?
The portfolio’s median borrower EBITDA at underwriting was about $30 million, and 72% of investments had financial covenants. Those characteristics point to a traditional middle-market underwriting approach rather than broadly syndicated lending. The adviser’s broader platform—more than $50 billion of assets under management and over 235 employees as described in the latest earnings release—can support sourcing and workout capabilities that a stand-alone small lender would struggle to replicate.
Which competitors pressure returns?
| Competitive group | Pressure on CCAP | CCAP response |
|---|---|---|
| Large public BDCs | Can underwrite larger deals, offer broader solutions, and borrow at scale | Focus on adviser relationships, selectivity, and middle-market niches |
| Private credit mega-funds | Compete aggressively for sponsor-backed loans and compress spreads | Use Crescent’s platform and long-standing sponsor network |
| Banks and syndicated markets | Re-enter attractive credits when liquidity is abundant | Offer execution certainty, customization, and hold capacity |
| Specialty lenders | Target the same sector verticals and covenant-rich opportunities | Differentiate through underwriting depth and portfolio monitoring |
How do credit quality, leverage, and dividends shape financial strength?
CCAP’s financial strength cannot be judged from net investment income alone. A lender can cover its dividend for several quarters while accumulating unrealized losses that reduce NAV and future earning capacity. The most useful reading therefore combines recurring income, credit migration, liquidity, leverage, and the relationship between payout and earnings.
Liquidity and leverage
| Financial measure | Latest reported value | Interpretation |
|---|---|---|
| Total assets | $1,617.7M at March 31, 2026 | Primarily the investment portfolio |
| Net assets | $674.0M at March 31, 2026 | The equity cushion supporting creditors and shareholders |
| Debt, net of financing costs | $907.1M at March 31, 2026 | Leverage magnifies both portfolio income and credit losses |
| Net debt-to-equity | 1.32x at March 31, 2026 | Higher than 1.20x at year-end 2025, reducing incremental flexibility |
| FY2025 net investment income | $66.9M, or $1.81 per share | Covered the $1.68 regular annual dividend by roughly 1.08x |
The annual baseline is available in CCAP’s 2025 Form 10-K filing. FY2025 investment income was $167.3 million, down from $197.4 million in FY2024, while net investment income fell to $66.9 million from $89.0 million. Lower benchmark rates and restructurings explain why a predominantly floating-rate asset book can experience earnings pressure even when portfolio size changes little.
Dividend coverage and capital deployment
During Q1 2026, CCAP funded $114.9 million of investments across 14 new portfolio companies and recorded $93.1 million of exits, sales, and repayments, producing $21.8 million of net funded activity. That positive deployment supports future interest income, but it also consumed leverage capacity at a time when non-accruals were rising. The fee reduction and lower $0.34 base dividend create more room for retained earnings and supplemental payouts, a more conservative capital-allocation posture than mechanically maintaining the former $0.42 base.
Who owns CCAP stock, and how is it governed?
CCAP uses one class of common stock with one vote per share. It is not founder-controlled through a dual-class structure, yet ownership is not completely diffuse: several institutions disclosed stakes above 5%, and the external adviser has substantial influence over strategy, underwriting, staffing, and portfolio management. The latest 2026 proxy statement is the primary source for these governance facts.
Who has voting influence?
| Holder or group | Reported stake | Source period | Why it matters |
|---|---|---|---|
| Texas County & District Retirement System | 13.53% | December 31, 2025 | Largest disclosed holder and a meaningful voting bloc |
| Blackstone ISG-I Advisors LLC | 11.38% | June 30, 2025 | Represents significant institutional economic exposure |
| Sun Life entities | 6.02% | September 30, 2024 | Connects an important shareholder to the adviser’s strategic parent |
| Directors and executive officers as a group | 1.23% | March 18, 2026 | Insider ownership exists but does not confer control |
How the external-manager structure changes governance
Chief Executive Officer Jason Breaux has led the company since 2015 and also holds senior roles within the adviser. That overlap can align portfolio strategy with the platform’s expertise, but it creates classic externally managed BDC conflicts: transaction allocation among affiliated funds, valuation judgments, and fee incentives. Independent directors, audit and governance committees, proxy voting, and the permanent 2026 fee reduction are therefore central to investor interpretation. The question is not simply whether management owns shares; it is whether contractual economics and board oversight keep the adviser focused on per-share NII and NAV rather than asset growth for its own sake.
Which opportunities, risks, and KPIs should researchers monitor?
CCAP’s opportunity set comes from the continued shift of middle-market lending from banks toward private credit, especially where borrowers value certainty, customization, and speed. Its principal risk is that attractive headline yields can be offset by restructurings, non-accruals, and fair-value losses. The Q1 2026 data show both sides: positive net deployment and lower adviser fees, but weaker NAV and deteriorating credit indicators.
What could improve or weaken the story?
Which KPIs matter most?
What matters most for valuation and the final takeaway?
A conventional industrial-company DCF starts with revenue, operating margin, taxes, capital spending, and free cash flow. A BDC requires a different emphasis because interest-bearing assets and debt financing are the operating business. The analytical core is projected net investment income per share, expected credit losses, NAV evolution, dividend capacity, and the market’s required return on equity.
How should a BDC be modeled?
The central valuation tension is visible in the latest results: NII remained sufficient to support a distribution, yet credit marks reduced NAV. A dividend-discount or residual-income approach should therefore use normalized NII after the new fee schedule, conservative loss assumptions, and a payout ratio consistent with RIC requirements. A price-to-NAV comparison can add context, but it should be adjusted for portfolio quality, leverage, fee burden, and expected return on equity rather than treated as a simple bargain signal.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
